Search results
Results from the WOW.Com Content Network
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
Together with Sandra Kooij, he found that ADHD in adults is a valid and distinct psychiatric disorder [21] and highlighted the chances of improvement in sleep quality and nocturnal motor activity in adults with ADHD through stimulant treatment. [22]
Some think that CDS and ADHD produce different kinds of inattention: While those with ADHD can engage their attention but fail to sustain it over time, people with CDS seem to have difficulty with engaging their attention to a specific task. [32] [33] Accordingly, the ability to orient attention has been found to be abnormal in CDS. [34]
Attention deficit hyperactivity disorder predominantly inattentive (ADHD-PI or ADHD-I), [3] is one of the three presentations of attention deficit hyperactivity disorder (ADHD). [4] In 1987–1994, there were no subtypes or presentations and thus it was not distinguished from hyperactive ADHD in the Diagnostic and Statistical Manual (DSM-III-R).
From 12% to 64% of families of a child with ADHD use an alternative therapy, [where?] with the lower estimates likely come from narrower definitions of complementary and alternative medicine (CAM). [1] School teachers, family and friends are the most common source of suggestion of alternative therapies for ADHD. [5]
A meta-analysis of the global prevalence of ADHD in adults, published in 2021, estimated a collective prevalence of persistent adult ADHD of 2.58% globally in 2020. [4] Persistent adult ADHD is defined as meeting diagnostic criteria for ADHD in adulthood with the additional requirement of a confirmed childhood diagnosis. [4]
Hallowell has been treating people of all ages with ADHD since 1981, and has stated that he has dyslexia [6] and ADHD, [7] which is self-diagnosed. [8] His approach to the condition uses a strength-based model—developed with Driven to Distraction co-author Dr. John Ratey—that is based on the tenets of positive psychology and takes a more holistic view of ADHD, rather than seeing it purely ...
Lisdexamfetamine, sold under the brand names Vyvanse and Elvanse among others, is a stimulant medication that is used to treat attention deficit hyperactivity disorder (ADHD) in children and adults and for moderate-to-severe binge eating disorder in adults. [16]